International Clinical Trial: A Randomized, Controlled, Multicenter Study Comparing the Efficacy and Safety of Percutaneous Ablation With or Without Furmonertinib in EGFR-Positive, Solid, Stage IA2-IA3 Non-Small Cell Lung Cancer

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126630) titled 'A Randomized, Controlled, Multicenter Study Comparing the Efficacy and Safety of Percutaneous Ablation With or Without Furmonertinib in EGFR-Positive, Solid, Stage IA2-IA3 Non-Small Cell Lung Cancer' on June 12.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University

Condition: Non-small cell lung cancer (NSCLC)

Intervention: Treatment Group:Oral furmonertinib mesilate tablets

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-16

Target Sample Size: Treatment Group:60;Follow-up Group:60;

Cou...